ClinConnect ClinConnect Logo
Search / Trial NCT02216500

Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

Launched by UNIVERSITY OF FLORIDA · Aug 12, 2014

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Ketogenic Therapy Ketogenic Diet

ClinConnect Summary

This clinical trial is studying how a special diet called the ketogenic diet affects children with seizures, especially those who do not respond well to standard treatments. The ketogenic diet is high in fats and low in carbohydrates, and it has been used for many years to help manage difficult-to-treat epilepsy. Researchers want to understand how this diet works and what the best ways are to use it.

To participate in the trial, children must have a doctor's recommendation for the ketogenic diet and must be able to follow the diet properly. They also need to have lab test results that show they can handle a high-fat, low-carb diet. However, children who cannot metabolize this type of diet or who may struggle to stick to the diet and keep accurate records will not be eligible. Participants will be part of a study that collects information on how the diet is affecting their seizures and overall health. This trial is open to children of all ages.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients whose physician has prescribed the ketogenic diet
  • Patients with lab tests consistent with the ability to metabolize a high fat and low carbohydrate diet
  • Patients that can be compliant with administration of the therapy and with record keeping.
  • Exclusion Criteria:
  • Patients with lab tests consistent with the inability to metabolize a high fat and low carbohydrate diet
  • Patients at risk of being non-compliant with administration of the therapy and with record keeping

About University Of Florida

The University of Florida, a leading research institution, is dedicated to advancing healthcare through innovative clinical trials. With a focus on enhancing patient outcomes and exploring new therapeutic avenues, the university leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct rigorous research across a variety of medical fields. Committed to ethical standards and patient safety, the University of Florida fosters collaboration among researchers, healthcare professionals, and community stakeholders to translate scientific discoveries into impactful clinical applications.

Locations

Gainesville, Florida, United States

Gainesville, Florida, United States

Patients applied

0 patients applied

Trial Officials

Peggy R. Borum, Ph.D.

Principal Investigator

University of Florida

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials